Courier Capital LLC Pfizer Inc Transaction History

Courier Capital LLC

  • $1.25 Billion
  • Q2 2024

A detailed history of Courier Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Courier Capital LLC holds 60,882 shares of PFE stock, worth $1.81 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
60,882
Previous 63,974 4.83%
Holding current value
$1.81 Million
Previous $1.78 Million 4.06%
% of portfolio
0.14%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024
SELL
$25.26 - $29.6 $78,103 - $91,523
-3,092 Reduced 4.83%
60,882 $1.7 Million
Q1 2024

Apr 15, 2024
SELL
$25.89 - $29.73 $1.51 Million - $1.73 Million
-58,150 Reduced 47.62%
63,974 $1.78 Million
Q4 2023

Jan 17, 2024
SELL
$26.13 - $33.94 $110,817 - $143,939
-4,241 Reduced 3.36%
122,124 $3.52 Million
Q3 2023

Oct 13, 2023
SELL
$32.09 - $37.51 $48,937 - $57,202
-1,525 Reduced 1.19%
126,365 $4.19 Million
Q2 2023

Jul 31, 2023
BUY
$36.12 - $41.79 $359,068 - $415,434
9,941 Added 8.43%
127,890 $4.69 Million
Q1 2023

May 18, 2023
SELL
$39.39 - $51.28 $204,867 - $266,707
-5,201 Reduced 4.22%
117,949 $4.81 Million
Q4 2022

Jan 24, 2023
SELL
$41.75 - $54.5 $108,466 - $141,591
-2,598 Reduced 2.07%
123,150 $0
Q3 2022

Oct 18, 2022
SELL
$43.76 - $53.42 $34,264 - $41,827
-783 Reduced 0.62%
125,748 $5.5 Million
Q2 2022

Jul 20, 2022
BUY
$46.53 - $55.17 $81,706 - $96,878
1,756 Added 1.41%
126,531 $6.63 Million
Q1 2022

May 02, 2022
SELL
$45.75 - $56.69 $226,096 - $280,161
-4,942 Reduced 3.81%
124,775 $6.46 Million
Q4 2021

Jan 18, 2022
SELL
$41.32 - $61.25 $192,220 - $284,935
-4,652 Reduced 3.46%
129,717 $7.66 Million
Q3 2021

Oct 14, 2021
SELL
$39.25 - $50.42 $34,383 - $44,167
-876 Reduced 0.65%
134,369 $5.78 Million
Q2 2021

Jul 12, 2021
SELL
$35.91 - $40.68 $150,750 - $170,774
-4,198 Reduced 3.01%
135,245 $5.3 Million
Q1 2021

Apr 12, 2021
BUY
$33.49 - $37.77 $438,116 - $494,107
13,082 Added 10.35%
139,443 $5.05 Million
Q4 2020

Feb 10, 2021
BUY
$33.47 - $42.56 $42,172 - $53,625
1,260 Added 1.01%
126,361 $4.65 Million
Q3 2020

Nov 09, 2020
SELL
$31.75 - $37.25 $93,567 - $109,775
-2,947 Reduced 2.3%
125,101 $4.55 Million
Q2 2020

Jul 06, 2020
BUY
$30.12 - $36.54 $178,039 - $215,987
5,911 Added 4.84%
128,048 $4.42 Million
Q1 2020

Apr 22, 2020
SELL
$27.03 - $38.62 $466,564 - $666,619
-17,261 Reduced 12.38%
122,137 $4.35 Million
Q4 2019

Jan 10, 2020
SELL
$32.92 - $37.36 $143,399 - $162,740
-4,356 Reduced 3.03%
139,398 $5.42 Million
Q3 2019

Oct 04, 2019
BUY
$32.49 - $42.13 $99,776 - $129,381
3,071 Added 2.18%
143,754 $5.1 Million
Q2 2019

Jul 16, 2019
SELL
$36.98 - $41.52 $279,346 - $313,642
-7,554 Reduced 5.1%
140,683 $6.09 Million
Q1 2019

Apr 25, 2019
SELL
$37.5 - $41.2 $58,762 - $64,560
-1,567 Reduced 1.05%
148,237 $6.3 Million
Q4 2018

Feb 08, 2019
SELL
$38.47 - $43.86 $215,008 - $245,133
-5,589 Reduced 3.6%
149,804 $6.54 Million
Q3 2018

Oct 12, 2018
SELL
$34.47 - $41.81 $123,540 - $149,847
-3,584 Reduced 2.25%
155,393 $6.85 Million
Q2 2018

Jul 19, 2018
SELL
$32.98 - $35.16 $32,155 - $34,281
-975 Reduced 0.61%
158,977 $5.77 Million
Q1 2018

Apr 27, 2018
SELL
$31.91 - $37.02 $25,017 - $29,023
-784 Reduced 0.49%
159,952 $5.68 Million
Q4 2017

Jan 25, 2018
SELL
$33.26 - $35.29 $173,550 - $184,143
-5,218 Reduced 3.14%
160,736 $5.82 Million
Q3 2017

Nov 03, 2017
BUY
$31.0 - $34.15 $3.15 Million - $3.47 Million
101,577 Added 157.78%
165,954 $5.93 Million
Q2 2017

Aug 10, 2017
BUY
N/A
64,377
64,377 $2.16 Million

Others Institutions Holding PFE

# of Institutions
3,218
Shares Held
3.71B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Courier Capital LLC Portfolio

Follow Courier Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Courier Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email